Note that some links may require registration or subscription.
Editors of The Lancet issued an “expression of concern” over the underlying data on a huge retrospective hydroxychloroquine study, which found use of the drug to be tied to worse mortality in COVID-19 patients.
As did editors of the New England Journal of Medicine, over a study from mostly the same authors on the effect of preexisting treatment with ACE inhibitors and ARBs on COVID-19; the journals have asked the study authors to furnish proof that their data are reliable.
North Carolina governor Roy Cooper (D) has turned down Republicans’ demands for a packed convention in his state in August, saying any such gathering would need to be smaller than normal due to the need for social distancing stemming from the pandemic. (Politico)
Adm. Brett Giroir, MD, who has been overseeing the COVID-19 testing ramp-up for the White House’s Coronavirus Task Force, will be going back to his job at the Department of Health and Human Services in the next few weeks. (Washington Times)
In the spirit of “don’t let a good crisis go to waste,” makers of the Puff Bar vaping device are being accused of using the pandemic to market their product to teenagers. (New York Times)
The unofficial U.S. tally as of 8:00 a.m. ET Wednesday was 1,831,821 cases and 106,181 deaths, up about 20,000 and 1,000, respectively, since yesterday.
China is disputing a report that it delayed sharing information with the World Health Organization in the early days of the pandemic. (Reuters)
Some changes the FDA is making to its processes during the pandemic may become permanent, said FDA Commissioner Stephen Hahn, MD. (Endpoints News)
Doctors in intensive care units (ICUs) are battling delirium in COVID-19 patients. (CNN/Kaiser Health News)
New York City ICUs are strangely quiet, and not just because they have fewer patients, writes emergency medicine physician Craig Spencer, MD. (Washington Post)
Some dentists are starting to charge a “COVID-19” fee — often not reimbursed by insurance — to cover the cost of additional PPE and other preventive measures. (NBC News/Kaiser Health News)
A vaccine could be available to part of the U.S. population by the end of the year, according to a vaccine researcher for the U.S. Army. (Reuters)
Though more than a quarter of U.S. adults say they wouldn’t get a COVID-19 vaccine, even if it were free. (ABC News)
And speaking of vaccines, a phase III trial of Moderna’s vaccine candidate will begin in July and involve 30,000 patients, according to NIAID director Anthony Fauci, MD. (Forbes)
Uh oh, Fido: the USDA announced the U.S.’s first case of a dog with COVID 19 — a German shepherd in New York. (The Hill)